IART Q3 2020 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$370M-2.3% YoY

Gross Profit

$235M63.6% margin

Operating Income

$58M15.5% margin

Net Income

$32M8.7% margin

EPS (Diluted)

$0.38

QoQ Revenue Growth

+43.1%

Cash Flow

Operating Cash Flow

$70M

Free Cash Flow

$63M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3.5B

Total Liabilities

$2.1B

Stockholders' Equity

$1.4B

Cash & Equivalents

$396M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$370M	$379M	-2.3%
Gross Profit	$235M	$236M	-0.4%
Operating Income	$58M	-$21M	+379.5%
Net Income	$32M	-$28M	+217.1%

Revenue Segments

Codman Specialty Surgical

$239M65%

Orthopedics and Tissue Technologies

$131M35%

Geographic Segments

UNITED STATES

$266M72%

Europe

$46M12%

Asia Pacific

$40M11%

Rest Of World

$17M5%